Poging GOUD - Vrij
Is PPE Shortage Driving Adoption Of Robots For Assistance?
Bio Spectrum
|June 2020
Anticipating the threat on healthcare workers in contracting corona infection, hospitals in India have started turning to robots for COVID-19 management. Robots help lessen exposure of healthcare workers to the virus thereby reducing danger of infection. They not only help in contactless screening but are also capable of other operations.
Keeping safe distance between individuals is hence one of the best tools considered to prevent spreading of SARS-CoV-19. However, certain professional duties present challenges to follow social distancing and falling in this category are majorly the healthcare workers, who are responsible for testing, diagnosis and treatment. A slight mishandling of the situation can lead to a health center becoming a hotspot of the disease.
The Directorate General of Health Services, Ministry of Health and Family Welfare has issued guidelines for rational use of Personal Protective Equipment (PPEs) such as gloves, coveralls/gowns, headcover, goggles, N-95 masks, shoe covers, face shields, triple-layer medical masks and body bags, to safeguard healthcare workers providing assistance in various settings of hospitals. Additionally, PPEs are also deployed by health workers in community settings as field staff, staff at quarantine facilities and home quarantine.
In a span of two months, India has emerged as the second-largest manufacturer of PPEs in the world. While India had no local manufacturing capacity of PPEs in February, and had experienced shortage for the same, a focused push for the ramp-up production was ensured for self-sufficiency. Though India managed to import around 52,000 PPE kits in February, the joint effort of Ministry of Textiles and India’s top textile manufacturers such as Arvind Mills, 3M, Aditya Birla, Alok Industries, JCT Phagwara, Gokaldas Exports, Indian Technical Textile Association (ITTA) with others, has led to the manufacturing of an average of current three lakh PPE kits per day.
Dit verhaal komt uit de June 2020-editie van Bio Spectrum.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Bio Spectrum
Bio Spectrum
Can India's CDMOS Lead the Next Biopharma Wave?
India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).
8 mins
March 2026
Bio Spectrum
Telangana turns catalyst for innovation
Telangana is at a pivotal moment in its journey as a global life sciences hub.
6 mins
March 2026
Bio Spectrum
Is AI the New Weapon in the Fight to End TB?
A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).
2 mins
March 2026
Bio Spectrum
ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India
US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.
1 min
March 2026
Bio Spectrum
Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy
Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.
5 mins
March 2026
Bio Spectrum
"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"
Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.
5 mins
March 2026
Bio Spectrum
Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer
Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.
1 min
March 2026
Bio Spectrum
Haleon ropes in Kedar Lele as President for India Subcontinent
Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.
1 min
March 2026
Bio Spectrum
Centre revises Startup Recognition Framework to strengthen Startup India Action Plan
The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.
1 min
March 2026
Bio Spectrum
"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"
In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.
5 mins
March 2026
Translate
Change font size

